The Motley Fool

Bull vs Bear: GlaxoSmithKline Plc

If you are looking for other buying opportunities, this new wealth report identifies five FTSE names that should provide you with a comfortable retirement. Just click here for details — it’s absolutely free.

Sign up for FREE issues of The Motley Fool Collective. Do you want straightforward views on what’s happening with the stock market, direct to your inbox? Help yourself with our FREE email newsletter designed to help you protect and grow your portfolio. Click here to get started now — it’s FREE!

In this Motley Fool video, Nate Weisshaar and Jill Ralph discuss the finer points of GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) as an investment opportunity.